2024
Categorical and Dimensional Approaches for Psychiatric Classification and Treatment Targeting: Considerations from Psychosis Biotypes
Clementz B, Assaf M, Sweeney J, Gershon E, Keedy S, Hill S, Ivleva E, Tamminga C, McDowell J, Keshavan M, Gibbons R, Carpenter W, Pearlson G. Categorical and Dimensional Approaches for Psychiatric Classification and Treatment Targeting: Considerations from Psychosis Biotypes. Advances In Neurobiology 2024, 40: 685-723. PMID: 39562461, DOI: 10.1007/978-3-031-69491-2_23.Peer-Reviewed Original ResearchConceptsIdiopathic psychosisBiotype-1Response to clozapineBipolar-Schizophrenia NetworkContinuum of severityReduced physiological responseDSM diagnosesNeurobiological distinctionsCategorical diagnosisSchizophrenia NetworkDiagnostic boundariesSalient stimuliPsychosis diagnosisPsychosis casesPsychiatric classificationPsychosis dataPsychosisBiotype-2Identified biotypesNeural activityIntermediate phenotypesTreatment targetElectrophysiological biomarkersElectrophysiological measurementsMedical model
2020
O3.4. PSYCHOSIS PHENOTYPES FROM B-SNIP FOR CLINICAL ADVANCES: BIOTYPE CHARACTERISTICS AND TARGETS
Clementz B, Trotti R, Pearlson G, Keshavan M, Gershon E, Keedy S, Ivleva E, McDowell J, Tamminga C. O3.4. PSYCHOSIS PHENOTYPES FROM B-SNIP FOR CLINICAL ADVANCES: BIOTYPE CHARACTERISTICS AND TARGETS. Schizophrenia Bulletin 2020, 46: s7-s7. PMCID: PMC7234003, DOI: 10.1093/schbul/sbaa028.015.Peer-Reviewed Original ResearchClinical featuresPsychosis biotypesPsychosis casesPsychosis syndromeTreatment targetsSpecific treatment targetsB-SNIPClinical manifestationsBiomarker profilesPsychosis subgroupsB-SNIP consortiumDeep phenotyping approachPathophysiological mechanismsPsychosis patientsBipolar-Schizophrenia NetworkPsychosis diagnosisBiological subtypesHealthy personsClinical practiceClinical advancesNegative symptomsClinical phenomenologySyndrome
2018
9.3 PSYCHOSIS BIOTYPES VERSUS CLINICAL SYNDROMES THROUGH THE PRISM OF INTRINSIC NEURAL ACTIVITY
Clementz B, Pearlson G, Tamminga C, Sweeney J, Keshavan M. 9.3 PSYCHOSIS BIOTYPES VERSUS CLINICAL SYNDROMES THROUGH THE PRISM OF INTRINSIC NEURAL ACTIVITY. Schizophrenia Bulletin 2018, 44: s14-s14. PMCID: PMC5888365, DOI: 10.1093/schbul/sby014.031.Peer-Reviewed Original ResearchInter-trial intervalNeural activityIntrinsic neural activityPsychosis biotypesDSM diagnosesSingle-trial powerOngoing neural activityBipolar-Schizophrenia NetworkHealthy personsStimulus salienceNeural responsesNeural oscillationsB-SNIPNeurobiological similaritiesNeurophysiological modelFirst-degree relativesEEG measuresTreatment developmentSensory cortexTranslational research programClinical featuresDistinct physiological mechanismsHealthy groupPsychosis diagnosisPsychosis cases